Company / Current Liabilities
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current Liabilities History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$285.6K
FY2015
5-year range
$261.2K / $350.7K
FY2011-FY2015
Trend
-11.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $261,152 to $285,642 over the past 3 years.
Based on SEC 10-K filings.
$285,642 in FY2015 with a 3-year CAGR of +3.0%.
Increased from $261,152 to $285,642 over the past 3 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.0%, indicating consistent growth.
- In FY2015, current liabilities decreased 11.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $285.6K | -11.2% |
| FY2013 | $321.8K | +23.2% |
| FY2012 | $261.2K | -25.5% |
| FY2011 | $350.7K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026